http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7781486-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d845d56b5ec6df36cd6f9582c965aad
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
filingDate 2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66072ad33c67a2ce60abb97a7e3e5ef6
publicationDate 2010-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7781486-B2
titleOfInvention Punctual stimulation therapy
abstract The invention relates to the use of a sterile aqueous solution of a substance inhibiting the enzymatic decomposition of endogenous opioide neuropeptides, especially enkephalins, for producing a preparation provided for intravenous infusion, in order to intensify the action of punctual stimulation therapy carried out with an electrical current. One such substance is e.g. D-phenylalanine. In cases that are difficult to treat, pain can be effectively reduced or stopped by infusion of the preparation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9662063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2561906-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130809-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9782584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10086199-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9901734-B2
priorityDate 2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4439452-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0004040-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197329-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4646744-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6955873-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9101756-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4331145-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5084007-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136168602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135969196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6852391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128590101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226470665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID673473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439524

Total number of triples: 48.